Trials / Completed
CompletedNCT05818020
Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies
Fighting Cancer Resistance: Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 269 (actual)
- Sponsor
- National Cancer Institute, Naples · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is multicentric, observational, and retro- prospective study.
Detailed description
The project aims to develop a regional platform for innovative disease treatment oncology. In particular, an integrated platform will be created with several complementary skills among them, which have as their common objective to increase knowledge and the possibilities of surgery for certain types of cancer. The actions implemented in this project will be as follows: * Improvement of primary and secondary prevention strategies with precocious diagnostic devices; * Optimization of therapeutic treatments by custom drawing of the scheme therapeutic; * Improved therapeutic efficacy for high social impact resistant neoplasms development of innovative treatments such as personalized therapeutic vaccines and small molecules; * Improving patient compliance and quality of life accompanied by less need of hospitalization of the patient himself with consequent decongestion of hospital admissions; * Reduction of health costs as a result of early diagnosis and new therapies more effective and less invasive; * Increasing regional health and technological attractiveness in a high bio-medical sector social and health impact.
Conditions
Timeline
- Start date
- 2020-03-02
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2023-04-18
- Last updated
- 2024-06-26
Locations
3 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT05818020. Inclusion in this directory is not an endorsement.